News release via CNW Telbec, Montreal 514-878-2520
Attention News/Health Editors:
Immunotec Inc. - Health Canada Approves Health Claim for HMS 90 /
IMMUNOCAL
MONTREAL, Nov. 13 /CNW Telbec/ - Immunotec Inc. (TSX-V IMM) announces
that it has received regulatory approval from Health Canada to market HMS 90 /
IMMUNOCAL with the following health claim: "a natural source of the
glutathione precursor cysteine for the maintenance of a strong immune system."
The Natural Health Products Directorate (NHPD) is Health Canada's
division responsible for the evaluation of the safety, efficacy and quality of
natural health products. It has issued a Natural Product Number (NPN) for
HMS 90 / IMMUNOCAL based on the credibility, strength and quality of evidence
provided to support the claim.
Immunotec strongly supports the implementation of the Natural Health
Products Regulation. President and Chief Executive Officer Jim Northrop notes:
"The imposition of high standards to ensure the quality, safety and efficacy
of natural products supports Immunotec's commitment to excellence in product
development and manufacturing. The issuance of this NPN reinforces to
consumers and Distributors alike that superb scientific evidence is the
foundation for HMS 90 / IMMUNOCAL. This fact, along with the important
associated health claim could have a significant impact on Immunotec's
business growth."
Senior Vice-President, Research & Development, Dr. Wulf Droge, is
extremely pleased about this regulatory approval. "What consumers have known
for quite some time has now been formally recognized by the NHPD: the health
benefits of Immunotec's lead product HMS 90 / IMMUNOCAL for the immune system
are based on solid science."
Natural Health Products must be manufactured, packaged, and labelled in
Health Canada-approved facilities according to current Good Manufacturing
Practices to ensure optimal quality of the finished goods. The evaluation of
the efficacy of a specific product allows consumers to make an informed choice
when including natural health pro